Pacific 8 Ventures is a venture capital firm that invests in early-stage startups at the intersection of disruptive technology platforms and healthcare, often as the first institutional investor. Their strategy focuses on companies transforming therapeutics, diagnostics, and broader health services, primarily within the United States, and they provide strategic support for market access.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (50% of deals). Average disclosed round size is $38.3M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$70M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 BillionToOne | Series C | $125M | Mar 2022 |
 Fauna Bio | Seed | $9M | Sep 2021 |
| BillionToOne | Series A | $15M | Mar 2020 |
| Fauna Bio | Seed | $4.1M | Apr 2019 |
Top Co-Investors
Hummingbird Ventures2 shared
Neotribe2 shared
Libertus2 shared
Civilization Ventures2 shared
True Ventures2 shared
Y Combinator1 shared
HOF Capital1 shared
Baillie Gifford1 shared
Norwest Venture Partners1 shared
Adams Street1 shared
Time BioVentures1 shared
Longevity Fund1 shared
Lifeforce Capital1 shared
BioMed Ventures1 shared
Vibe Capital1 shared
Last updated: 12 April 2026